Differences between both studies might be explained by differences in experimental settings including for example the use of different mouse sources, and the application of bone marrow transplantation towards Ldlr−/−mice versus PCSK9-AAV injection to elicit atherosclerosis. The gene discussed is PCSK9; the disease is atherosclerosis.